Companies / Czech Republic
Sanofi-Aventis Leads Foreign Charge Into Generics Sector
March 2006 | FDI AlertFrench drug major Sanofi-Aventis has bought a 24.9% stake in Czech generic firm Zentiva for EUR430mn (US$517mn) to further penetrate markets in Eastern and Central
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.



